Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...

New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Potential COVID-19 vaccine vials from Pfizer, Oct. 31, 2020. Dado Ruvic/Reuters, FILE Early data revealed Monday that Pfizer's COVID-19 vaccine candidate could be up to 90% effective .

When compared to its XBB vaccine, Pfizer’s KP.2 COVID-19 vaccine offered up to a 7.3-times stronger response in mice infected with KP.2 and several other JN variants, according to trial data.

* FDA SPOKESPERSON SAYS "GIVEN THE PUBLIC HEALTH EMERGENCY, FDA IS ADVISING THAT IT IS ACCEPTABLE TO USE EVERY FULL DOSE OBTAINABLE" - POLITICO * PHARMACISTS HAVE FOUND WAY TO SQUEEZE EXTRA DOSES ...

Dr. Jason Smith, who received the first vaccine in Kentucky, still carries the empty vial as a reminder that there's always hope, even in the darkest times. On Dec. 14, 2020, ...

Key Background. Pfizer and BioNTech announced the results of their Covid vaccine on Nov. 9, 2020, six days after Election Day. Former President Joe Biden was declared the winner of the 2020 ...

The U.S. Food and Drug Administration said on Wednesday that extra doses from vials of Pfizer Inc's COVID-19 vaccine can be used after reports of vaccine doses being thrown away by pharmacists due ...

Pfizer and BioNTech's COVID-19 vaccine is 100% effective against the virus in children ages 12 to 15, the companies announced in a press release Wednesday.. In a placebo-controlled trial of 2,260 ...